Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Tafa5 | Mouse | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM19A5 mRNA | CTD | PMID:36331819 | Tafa5 | Mouse | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of FAM19A5 mRNA | CTD | PMID:28960355 | Tafa5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Tafa5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TAFA5 mRNA | CTD | PMID:32109520 | Tafa5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TAFA5 mRNA | CTD | PMID:26377647 | Tafa5 | Mouse | 4,4'-sulfonyldiphenol | decreases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of TAFA5 gene | CTD | PMID:31601247 | Tafa5 | Mouse | 4,4'-sulfonyldiphenol | affects methylation | EXP | | 6480464 | bisphenol S affects the methylation of FAM19A5 gene | CTD | PMID:31683443 | Tafa5 | Mouse | 8-Br-cAMP | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TAFA5 mRNA | CTD | PMID:22079614 | Tafa5 | Mouse | acrylamide | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of TAFA5 mRNA | CTD | PMID:32763439 | Tafa5 | Mouse | aflatoxin B1 | increases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of TAFA5 intron | CTD | PMID:30157460 | Tafa5 | Mouse | Aflatoxin B2 alpha | increases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of TAFA5 intron | CTD | PMID:30157460 | Tafa5 | Mouse | all-trans-retinoic acid | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of TAFA5 mRNA | CTD | PMID:21934132 | Tafa5 | Mouse | alpha-Zearalanol | multiple interactions | ISO | Tafa5 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FAM19A5 mRNA and [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of FAM19A5 mRNA | CTD | PMID:35163327 | Tafa5 | Mouse | arsane | affects methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | Arsenic affects the methylation of TAFA5 gene | CTD | PMID:25304211 | Tafa5 | Mouse | arsenic atom | affects methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | Arsenic affects the methylation of TAFA5 gene | CTD | PMID:25304211 | Tafa5 | Mouse | arsenous acid | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of TAFA5 mRNA | CTD | PMID:20458559 | Tafa5 | Mouse | atrazine | affects methylation | ISO | Tafa5 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of TAFA5 gene | CTD | PMID:35440735 | Tafa5 | Mouse | azathioprine | decreases expression | EXP | | 6480464 | Azathioprine results in decreased expression of TAFA5 mRNA | CTD | PMID:21621594 | Tafa5 | Mouse | benzo[a]pyrene | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of TAFA5 mRNA | CTD | PMID:20106945 and PMID:21632981 | Tafa5 | Mouse | benzo[a]pyrene | affects methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of FAM19A5 3' UTR and Benzo(a)pyrene affects the methylation of FAM19A5 promoter | CTD | PMID:27901495 | Tafa5 | Mouse | benzo[a]pyrene | increases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of FAM19A5 exon | CTD | PMID:27901495 | Tafa5 | Mouse | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of FAM19A5 intron and Benzo(a)pyrene results in increased methylation of FAM19A5 promoter | CTD | PMID:27901495 | Tafa5 | Mouse | benzo[e]pyrene | increases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of TAFA5 intron | CTD | PMID:30157460 | Tafa5 | Mouse | bisphenol A | affects expression | ISO | TAFA5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of TAFA5 mRNA | CTD | PMID:30903817 | Tafa5 | Mouse | bisphenol A | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of TAFA5 gene | CTD | PMID:31601247 | Tafa5 | Mouse | bisphenol A | decreases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of TAFA5 gene | CTD | PMID:31601247 | Tafa5 | Mouse | bisphenol A | increases methylation | ISO | Tafa5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of TAFA5 gene | CTD | PMID:28505145 | Tafa5 | Mouse | bisphenol A | decreases expression | ISO | Tafa5 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of TAFA5 mRNA | CTD | PMID:25181051 | Tafa5 | Mouse | cadmium atom | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TAFA5 mRNA | CTD | PMID:35301059 | Tafa5 | Mouse | cadmium dichloride | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TAFA5 mRNA | CTD | PMID:35301059 | Tafa5 | Mouse | CGP 52608 | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to FAM19A5 gene] | CTD | PMID:28238834 | Tafa5 | Mouse | cisplatin | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of TAFA5 mRNA | CTD | PMID:27392435 | Tafa5 | Mouse | cisplatin | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of TAFA5 mRNA | CTD | PMID:27392435 | Tafa5 | Mouse | clothianidin | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | clothianidin results in increased expression of FAM19A5 mRNA | CTD | PMID:31626844 | Tafa5 | Mouse | copper(II) sulfate | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of TAFA5 mRNA | CTD | PMID:19549813 | Tafa5 | Mouse | cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of TAFA5 mRNA | CTD | PMID:21621594 | Tafa5 | Mouse | cyclosporin A | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of TAFA5 mRNA | CTD | PMID:25562108 | Tafa5 | Mouse | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of TAFA5 mRNA | CTD | PMID:21621594 | Tafa5 | Mouse | cyclosporin A | decreases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of TAFA5 promoter | CTD | PMID:27989131 | Tafa5 | Mouse | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of TAFA5 mRNA | CTD | PMID:21621594 | Tafa5 | Mouse | diarsenic trioxide | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of TAFA5 mRNA | CTD | PMID:20458559 | Tafa5 | Mouse | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of TAFA5 mRNA | CTD | PMID:21266533 | Tafa5 | Mouse | dorsomorphin | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Tafa5 | Mouse | endosulfan | increases expression | ISO | Tafa5 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of TAFA5 mRNA | CTD | PMID:29391264 | Tafa5 | Mouse | fulvestrant | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of TAFA5 gene | CTD | PMID:31601247 | Tafa5 | Mouse | maneb | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of FAM19A5 mRNA | CTD | PMID:36117858 | Tafa5 | Mouse | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of TAFA5 mRNA | CTD | PMID:26307267 | Tafa5 | Mouse | methapyrilene | increases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of TAFA5 intron | CTD | PMID:30157460 | Tafa5 | Mouse | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of TAFA5 mRNA | CTD | PMID:21621594 | Tafa5 | Mouse | methoxychlor | affects methylation | ISO | Tafa5 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of TAFA5 gene | CTD | PMID:35440735 | Tafa5 | Mouse | methylmercury chloride | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of TAFA5 mRNA | CTD | PMID:26272509 | Tafa5 | Mouse | methylmercury chloride | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAFA5 mRNA | CTD | PMID:27188386 | Tafa5 | Mouse | N-methyl-4-phenylpyridinium | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of TAFA5 mRNA | CTD | PMID:24810058 | Tafa5 | Mouse | nickel atom | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Nickel results in decreased expression of TAFA5 mRNA | CTD | PMID:25583101 | Tafa5 | Mouse | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of FAM19A5 mRNA | CTD | PMID:31626304 | Tafa5 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TAFA5 mRNA | CTD | PMID:34911549 | Tafa5 | Mouse | paraquat | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of FAM19A5 mRNA | CTD | PMID:36117858 | Tafa5 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM19A5 mRNA | CTD | PMID:36331819 | Tafa5 | Mouse | perfluorooctanoic acid | multiple interactions | ISO | Tafa5 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FAM19A5 mRNA and [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of FAM19A5 mRNA | CTD | PMID:35163327 | Tafa5 | Mouse | phenylmercury acetate | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of TAFA5 mRNA | CTD | PMID:26272509 | Tafa5 | Mouse | phenylmercury acetate | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAFA5 mRNA | CTD | PMID:27188386 | Tafa5 | Mouse | prednisolone | increases expression | EXP | | 6480464 | Prednisolone results in increased expression of TAFA5 mRNA | CTD | PMID:21621594 | Tafa5 | Mouse | quercetin | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of TAFA5 mRNA | CTD | PMID:21632981 | Tafa5 | Mouse | resorcinol | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | resorcinol results in increased expression of TAFA5 mRNA | CTD | PMID:22623647 | Tafa5 | Mouse | SB 431542 | multiple interactions | ISO | TAFA5 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Tafa5 | Mouse | silicon dioxide | decreases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of TAFA5 mRNA | CTD | PMID:25895662 | Tafa5 | Mouse | silicon dioxide | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of TAFA5 mRNA | CTD | PMID:23806026 | Tafa5 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of FAM19A5 promoter | CTD | PMID:35295148 | Tafa5 | Mouse | trichloroethene | increases expression | ISO | Tafa5 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of FAM19A5 mRNA | CTD | PMID:33387578 | Tafa5 | Mouse | valproic acid | increases expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TAFA5 mRNA | CTD | PMID:19101580 and PMID:29154799 | Tafa5 | Mouse | valproic acid | affects expression | ISO | TAFA5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TAFA5 mRNA | CTD | PMID:25979313 | Tafa5 | Mouse | valproic acid | increases methylation | ISO | TAFA5 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of TAFA5 gene | CTD | PMID:29154799 | Tafa5 | Mouse | vinclozolin | affects expression | ISO | Tafa5 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of TAFA5 mRNA | CTD | PMID:19015723 | |